XML 81 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue:        
Total revenue $ 5,285,000 $ 4,211,000 $ 10,237,000 $ 8,082,000
Costs and expenses:        
Cost of revenue 5,499,000 5,673,000 10,685,000 10,663,000
Selling, general and administrative (including stock based compensation) 3,211,000 3,473,000 6,703,000 7,035,000
Total costs and expenses 8,710,000 9,146,000 17,388,000 17,698,000
Operating loss (3,425,000) (4,935,000) (7,151,000) (9,616,000)
Other income (expense):        
Interest income 25,000 195,000 33,000 302,000
Other income 1,000 12,000 10,000 38,000
Interest expense (123,000) (142,000) (156,000) (190,000)
Foreign Currency Translation Adjustment 3,000 (9,000) (14,000)
(Loss)/gain on equity method investment (2,000) 8,000 (5,000) 7,000
Gain (loss) on investments 1,557,000 (383,000) 627,000 (572,000)
Impairment of intangible assets (600,000) (600,000)
Provision for loan losses (53,000) (346,000)
(Loss)/gain on sale (43,000) 165,000 (727,000) 165,000
Loss from operations before income taxes (2,607,000) (5,142,000) (7,969,000) (10,226,000)
Income tax benefit 188,000 67,000 163,000
Net loss (2,607,000) (4,954,000) (7,902,000) (10,063,000)
Loss from operations attributed to noncontrolling interest 455,000 271,000 973,000 1,309,000
Net loss attributable to DSS common stockholders $ (2,152,000) $ (4,683,000) $ (6,929,000) $ (8,754,000)
Loss per common share attributable to common stockholders        
Basic $ (0.24) $ (0.66) $ (0.78) $ (1.24)
Diluted $ (0.24) $ (0.66) $ (0.78) $ (1.24)
Shares used in computing loss per common share:        
Basic 9,092,518 7,066,772 8,889,221 7,066,772
Diluted 9,092,518 7,066,772 8,889,221 7,066,772
Printed Products [Member]        
Revenue:        
Total revenue $ 4,272,000 $ 3,527,000 $ 8,255,000 $ 6,599,000
Rental Income [Member]        
Revenue:        
Total revenue 715,000 438,000 1,429,000 838,000
Net Investment Income [Member]        
Revenue:        
Total revenue 9,000 41,000 29,000 136,000
Commission Revenue [Member]        
Revenue:        
Total revenue 282,000 204,000 503,000 507,000
Biotechnology Retail Sales [Member]        
Revenue:        
Total revenue $ 7,000 $ 1,000 $ 21,000 $ 2,000